Parkinson’s Disease / 2014 / Article / Fig 1

Clinical Study

Parkinson’s Disease: Low-Dose Haloperidol Increases Dopamine Receptor Sensitivity and Clinical Response

Figure 1

An add-on oral dose of 40 μg haloperidol per day enhanced the effectiveness of levodopa in treating Parkinson disease patients, as monitored by the SCOPA ratings. (a) Data for all 16 patients. (b) Data for 12 patients, where four advanced stage patients were omitted. Data in Tables 1 and 2.
(a)
(b)

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.